US BANCORP \DE\

Bank

Position in COGT — Cogent Biosciences, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in COGT

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$449,383

-$20,578 QoQ

Shares Held

11,612

-4.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#213

of 321 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. COGT ranks #25 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,383	11,612	-4.9%	Shares	Defined	2026-08-12
2026-03-31	$469,961	12,210	+7627.8%	Shares	Defined	2026-05-15
2025-12-31	$5,612	158	+409.7%	Shares	Defined	2026-01-30
2025-06-30	$222	31	-86.3%	Shares	Defined	2025-07-24
2025-03-31	$1,353	226	+65.0%	Shares	Defined	2025-05-08
2024-06-30	$1,154	137	-44.1%	Shares	Defined	2024-08-07
2023-09-30	$2,388	245	-43.4%	Shares	Defined	2023-11-03
2023-06-30	$5,126	433	-86.7%	Shares	Defined	2023-08-10
2023-03-31	$35,002	3,244	-13.3%	Shares	Defined	2023-05-09
2022-12-31	$43,257	3,742	+68.3%	Shares	Defined	2023-02-13
2022-09-30	$33,182	2,224	+70.9%	Shares	Defined	2022-10-27
2022-06-30	$11,735	1,301	+2032.8%	Shares	Defined	2022-08-01
2021-06-30	$494	61	—	Shares	Defined	2021-08-05
No filing history on record for this holder in this stock.